Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease
Background: Neural stem cell (NSC) proliferation and differentiation in the mammalian brain decreases to minimal levels postnatally. Nevertheless, neurogenic niches persist in the adult cortex and hippocampus in rodents, primates and humans, with adult NSC differentiation sharing key regulatory mech...
Main Authors: | Charou, D, Rogdakis, T, Latorrata, A, Valcarcel, M, Papadogiannis, V, Athanasiou, C, Tsengenes, A, Papadopoulou, MA, Lypitkas, D, Lavigne, MD, Katsila, T, Wade, RC, Cader, MZ, Calogeropoulou, T, Gravanis, A, Charalampopoulos, I |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2024
|
Similar Items
-
A quest for the stereo-electronic requirements for selective agonism for the neurotrophin receptors TrkA and TrkB in 17-spirocyclic-dehydroepiandrosterone derivatives
by: Daniele Narducci, et al.
Published: (2023-09-01) -
Development and Biological Characterization of a Novel Selective TrkA Agonist with Neuroprotective Properties against Amyloid Toxicity
by: Thanasis Rogdakis, et al.
Published: (2022-03-01) -
Development of Pleiotropic TrkB and 5-HT<sub>4</sub> Receptor Ligands as Neuroprotective Agents
by: Mirjana Antonijevic, et al.
Published: (2024-01-01) -
Butanolides and Butenolides from a Marine-Derived <i>Streptomyces</i> sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor
by: Paolo Giaccio, et al.
Published: (2023-08-01) -
Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours
by: Yuehua Li, et al.
Published: (2023-03-01)